Havens Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Havens Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-80,000	Closed	-$1.51M	–	42
2019 Q3	$1.51M	Buy	+80,000	New	+$915K	1.37%	22

Havens Advisors's ALDR Position: Q4 2019 in Review

Havens Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 80,000 shares — an estimated $1.51M sold.

Havens Advisors first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $1.51M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Havens Advisors reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Havens Advisors sold 80,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.51M.
Havens Advisors first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Havens Advisors's Alder Biopharmaceuticals position peaked at $1.51M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Havens Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.